picture-profile-icon-male-icon-human-or-people-sign-and-symbol-free-vector-scaled-1-1.jpg

Abolaji Olagunju

PhD Candidate
WG Members
University of Sao Paulo, Brazil.
Brazil
WGs: WG1, WG2
Research Keywords: Cancer, Vaccine, Immunotherapy , Immunology, Cell death
Personal Statement: I am a final-year PhD student at the University of Sao Paulo, Brazil, currently working on the activation and effector function of in vivo CD8+ T cells using live recombinant Listeria monocytogenes to elicit a robust anti-tumor immune response in combination with the cell death pathways (necroptosis and pyroptosis).
Tumor type: Other
Models in use: Ex vivo, In vivo
Immune cells of interest: T lymphocytes, Dendritic cells, Granulocytes, Monocytes/macrophages, NK cells
Seeking: Collaborations on targeted immunotherapy approaches using neoantigens and cell-based therapies.
Offering: Expert in immunology techniques such as multi-color flow cytometry, adoptive cell transfer.

Join us

How to Participate

The COST Action IMMUNO-model welcomes research-active scientists working in the field.

How to Get Involved

  • Read the Project Description MoU;
  •  Inform the Main Proposer/Chair of your interest (email);
  • Apply to join your Working Groups of interest;
  • You will be informed by the working group leaders as soon as your application has been reviewed;
  • Please note, Management Committee nominations are carried out through the COST National Contact Points.

How to participate in an existing Action?

If you would like to join this COST Action please ensure that you read the guidance notes published on the COST website. You can find full documentation regarding general rules and guidelines for COST Actions at www.cost.eu/participate.

Subscribe to our newsletter